Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Aflibercept

Brand: Eylea ®
NICE TA: 294
Indication: Wet age-related macular degeneration (NICE TA294)
Disease category: Eye
Commissioning responsibility: CCG
PbR excluded: Yes

Background

Aflibercept solution for injection is recommended as an option for treating wet age-related macular degeneration only if:
• it is used in accordance with the recommendations for ranibizumab in NICE technology appraisal guidance 155 (re-issued in May 2012) and
• the manufacturer provides aflibercept solution for injection with the discount agreed in the patient access scheme.

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Red

Red

Red

Red

Red